0001181431-11-018577.txt : 20110317 0001181431-11-018577.hdr.sgml : 20110317 20110317081504 ACCESSION NUMBER: 0001181431-11-018577 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110315 FILED AS OF DATE: 20110317 DATE AS OF CHANGE: 20110317 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Reisenauer Mark L CENTRAL INDEX KEY: 0001413481 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50440 FILM NUMBER: 11693658 MAIL ADDRESS: STREET 1: 6707 DEMOCRACY BOULEVARD STREET 2: SUITE 505 CITY: BETHESDA STATE: MD ZIP: 20817 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MICROMET, INC. CENTRAL INDEX KEY: 0001131907 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 522243564 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6707 DEMOCRACY BOULEVARD STREET 2: SUITE 505 CITY: BETHESDA STATE: MD ZIP: 20817 BUSINESS PHONE: 240-752-1420 MAIL ADDRESS: STREET 1: 6707 DEMOCRACY BOULEVARD STREET 2: SUITE 505 CITY: BETHESDA STATE: MD ZIP: 20817 FORMER COMPANY: FORMER CONFORMED NAME: CANCERVAX CORP DATE OF NAME CHANGE: 20010108 4 1 rrd305679.xml REISENAUER FORM 4 X0303 4 2011-03-15 0 0001131907 MICROMET, INC. MITI 0001413481 Reisenauer Mark L 6707 DEMOCRACY BLVD BETHESDA MD 20817 0 1 0 0 SVP, Chief Commercial Officer Common Stock 2011-03-15 4 M 0 111100 1.98 D 111100 D Common Stock 2011-03-15 4 S 0 111100 5.1085 D 0 D Stock Option (right to buy) 1.98 2011-03-15 4 M 0 90909 0 D 2011-03-01 2017-10-01 Common Stock 90909 35354 D Stock Option (right to buy) 1.98 2011-03-15 4 M 0 20191 0 D 2010-12-01 2017-10-01 Common Stock 20191 28547 D Price reflected is the weighed-average sale price for shares sold. The range of sale prices for the transactions reported was $5.10 to $5.1274 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Twenty-five percent of the shares underlying this option vested on October 1, 2008, with the remainder vesting in equal monthly installments through October 1, 2011. /s/ Janet Hanson, attorney-in-fact 2011-03-17